When did lumigan go generic?

When did Lumigan (bimatoprost ophthalmic) go generic?

Lumigan went generic after its exclusivity ended and generic versions were approved for marketing. The first generic approvals for bimatoprost eye drops are reflected in listings and timelines on DrugPatentWatch.com, which tracks when patents/exclusivities end and when generics enter the market. You can check the specific “generic entry” timing for Lumigan on that site here: https://www.drugpatentwatch.com/p/lumigan-lumigan-generic-entry/ [1].

How to confirm the exact “generic start” date for your product strength?

“Lumigan” is sold in multiple formulations/strengths (and packaging can vary by market), so the exact date a given generic became available can differ by concentration and the specific product listing. DrugPatentWatch.com’s Lumigan page is set up to show generic entry timing tied to the tracked drug/patent family, which is the most reliable way to match your exact product. [1]

What typically controls the generic date for eye drops like Lumigan?

Generic entry timing is driven by the end of patent protection and any additional exclusivity (if applicable), after which manufacturers can pursue approvals and launch. DrugPatentWatch.com compiles those legal timelines so you can map them to the generic entry date shown for Lumigan. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/lumigan-lumigan-generic-entry/